BECK BODE, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
BECK BODE, LLC portfolio value:
$297,000
portfolio value
BECK BODE, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.94% | 4 shares | 45K | $688.87 | 431 |
Q2 2022 | share | Decrease | -5.95% | -27 shares | -65K | $591.13 | 427 |
Q1 2022 | share | Increase | 0.00% | 454 shares | 317K | $698.42 | 454 |
Q4 2021 | share | Decrease | -100.00% | -12.68K shares | -7.67M | $642.51 | 0 |
Q3 2021 | share | Decrease | -1.48% | -191 shares | 484K | $605.18 | 12.68K |
Q2 2021 | share | Increase | +0.39% | 50 shares | 1.12M | $558.54 | 12.87K |
Q1 2021 | share | Increase | +34554.05% | 12.78K shares | 6.04M | $473.14 | 12.82K |
Q3 2020 | share | Increase | 0.00% | 37 shares | 21K | $559.78 | 37 |
Q2 2020 | share | Decrease | -100.00% | -6.13K shares | -3.22M | $623.65 | 0 |
Q1 2020 | share | Increase | 0.00% | 6.13K shares | 3.22M | $488.29 | 6.13K |